Some clinical studies have preliminarily suggested lower HDL-C levels in IBD patients (37, 38, 39), and significantly increased after corticosteroids, anti-TNFα or tofacitinib treatment (40), and high HDL-C is positively associated with mucosal healing (41). This evidence concerns the gene TNF and inflammatory bowel disease.